TFOAX
Price
$71.81
Change
-$0.22 (-0.31%)
Updated
Sep 20 closing price
VITSX
Price
$136.99
Change
-$0.34 (-0.25%)
Updated
Sep 20 closing price
Ad is loading...

TFOAX vs VITSX

Header iconTFOAX vs VITSX Comparison
Open Charts TFOAX vs VITSXBanner chart's image
Touchstone Focused A
Price$71.81
Change-$0.22 (-0.31%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Market Idx I
Price$136.99
Change-$0.34 (-0.25%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
TFOAX vs VITSX Comparison Chart
Loading...
VS
TFOAX vs. VITSX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TFOAX is a StrongBuy and VITSX is a Buy.

FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.72T vs. TFOAX (1.3B). VITSX pays higher dividends than TFOAX: VITSX (1.36) vs TFOAX (0.00). TFOAX was incepted earlier than VITSX: TFOAX (21 years) vs VITSX (27 years). TFOAX is a more actively managed with annual turnover of: 5.00 vs. VITSX (2.00). TFOAX has a lower initial minimum investment than VITSX: TFOAX (2500) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 31.57 vs. TFOAX (24.24). VITSX return over 5 years is better than : 85.68 vs. TFOAX (64.38).
TFOAXVITSXTFOAX / VITSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years27 years-
Gain YTD15.61718.65184%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.3B1.72T0%
Annual Yield % from dividends0.001.36-
Returns for 1 year24.2431.5777%
Returns for 3 years13.5725.3653%
Returns for 5 years64.3885.6875%
Returns for 10 years104.91188.3456%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OKTA75.790.77
+1.03%
Okta
UAA7.990.06
+0.76%
Under Armour
JYNT11.43-0.47
-3.95%
Joint Corp (The)
ABCL2.59-0.15
-5.47%
AbCellera Biologics
ADN3.14-0.24
-7.10%
Advent Technologies Holdings Inc.